ClinicalTrials.gov
public full text
Public Domain
Urinary KIM-1 After Vancomycin or Linezolid Administration
Acute renal injury is a common complication of critical illness. Drug induced renal insult compounds the degree of injury in many patients, and a great deal of research has focused on prevention of this complication. Traditional biomarkers of renal injury like serum creatinine and blood urea nitrogen content fail to consistently predict harm among patients at risk. Kidney Injury Molecule 1 (KIM-1) will be studied as a biomarker of renal injury.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Renal Protection of Intravenous Dexmedetomidine During Radical Cystectomy#872901
- Clinical Values of Automated Electronic Alert for Acute Kidney Injury#1088165
- Molecular Survival Strategies Against Kidney Filtration: Implications for Therapeutic Protein Engineering.#412212
- Molecular Survival Strategies Against Kidney Filtration: Implications for Therapeutic Protein Engineering#390811
- A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)#1111566
Record · ID 865477
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive